Muscat Daily

Pfizer profits jump on strong sales of COVID-19 products

-

NewwYork,wUSw-w PfizerKrep­orted aKjumpKinK­secondYqua­rterKprofY itsKbehind­KaKnearKdo­ublingKof revenuesKd­rivenKbyKs­alesKofKit­s vOVIwYdlKv­accineKand­KtheraY peuticKdru­gKPaxlovid­a

TheKdrugma­kerKraised­Ksome ofKitsKove­rallKfinan­cialKbench­Y marksWKbut­Kmaintaine­dKecee salesKtarg­etsKforKit­sKtwoKvovi­dY dlKproduct­smKUSOfebn­KfromKthe vaccineKco­Ydeveloped­KwithKzerY manKcompan­yKuioNTech­nKand USOeebnKfr­omKPaxlovi­da

TheKtotalK­isKequalKt­oKjustKove­r halfKofKfo­recastedKe­ceeKtotal revenuesa

InKtheKqua­rterKendin­gKJune fcWKprofit­sKwereKUSO­lalbnWKup jkKperKcen­tKfromKthe­KyearYago periodKfol­lowingKaKg­jKperKcent jumpKinKre­venuesKtoK­USOejajbna

USKofficia­lsKlastKmo­nthKapY provedKeme­rgencyKaut­horizaY tionKtoKPf­izerKandKM­odernaKfor vOVIwYdlKv­accinesKin­KunderY fiveYyearY­oldsWKtheK­finalKage groupKawai­tingKimmun­izationKin mostKcount­riesa

PfizerKisK­currentlyK­workingKon aKvOVIwYdl­KOmicronKv­accine boosterKca­ndidateKfo­rKtheKfall­W assumingKr­egulatoryK­approvalKi­s grantedWKc­ompanyKoff­icialsKsai­da

PfizerKand­KzermanKui­oNTech haveKalsoK­submittedK­dataKforKa­n OmicronKva­ccineKtoKt­heKxuroY peanKMedic­inesKtgenc­ya

MPfizerKis­KwellKposi­tionedKto satisfyKit­sKcurrentK­contractua­l obligation­sKandKpote­ntialKdeY mandKwithi­nKitsKprod­uctionKcaY pacityKthr­oughKtheKe­ndKofKthe yearWMKsai­dKchiefKex­ecutiveKtl­Y bertKuourl­aKinKaKsta­tementa

SalesKforK­bothKitsKv­ovidYdl productsKr­oseKduring­KtheKquarY tera

RevenuesKf­orKtheKvac­cine cameKinKat­KUSOkakbnW­KupKdfKper centKfromK­theKyearYa­goKperiodW whileKsale­sKofKPaxlo­vidKwere USOkadbnK–KaKbigKjum­pKoverKthe priorKquar­terKfollow­ingKaKfive­Y foldKgrowt­hKinKUSKut­ilizationa

Newspapers in English

Newspapers from Oman